4Filing Date: Mar 17, 2026

Guardant Health (GH) 4: Talasaz AmirAli sold 13,209 shares of Common Stock at $N/A… (Mar 17, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001753159-26-000006
Total Value$3.15M
Trades9
Insiders1

Transaction Details

Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Grant · Acquire
Restricted Stock UnitsDerivative
Shares+101.41K
Price$0.00
Total Value$0
Shares Owned After101.41K
Transaction DateMar 17, 2026
Footnotes ▸

This represents a restricted stock unit award granted on March 17, 2026 that vests over a three-year period. 33% of the shares subject to such award vests on January 1, 2027 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Grant · Acquire
Restricted Stock UnitsDerivative
Shares+11.27K
Price$0.00
Total Value$0
Shares Owned After11.27K
Transaction DateMar 17, 2026
Footnotes ▸

This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. | Not applicable for Restricted Stock Units.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Tax W/H · Dispose
Common Stock
Shares-13.66K
Price$85.49
Total Value$1.17M
Shares Owned After2.13M
Transaction DateMar 13, 2026
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Exercise · Acquire
Common Stock
Shares+26.96K
Price$0.00
Total Value$0
Shares Owned After2.14M
Transaction DateMar 13, 2026
Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Exercise · Dispose
Performance-Based Restricted Stock UnitsDerivative
Shares-26.96K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateMar 13, 2026
Footnotes ▸

Not applicable for Restricted Stock Units.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-38.28K
Price$0.00
Total Value$0
Shares Owned After77.73K
Transaction DateJan 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on March 12, 2025 that vested with respect to 33% of the shares on January 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Exercise · Acquire
Common Stock
Shares+38.28K
Price$0.00
Total Value$0
Shares Owned After2.13M
Transaction DateJan 1, 2026
Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Other · Dispose
Common Stock
Shares-13.21K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateJan 1, 2026
Footnotes ▸

Reflects changes in form of ownership from direct to indirect due to transfer of shares to Talasaz and Eskandari 2017 Family Trust.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Tax W/H · Dispose
Common Stock
Shares-19.40K
Price$102.14
Total Value$1.98M
Shares Owned After2.12M
Transaction DateJan 1, 2026
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Post-Transaction Holdings

Talasaz AmirAli · Co-Chief Executive Officer, Director
SecuritySharesChange
Common Stock2.13M+18.97K (0.90%)
Performance-Based Restricted Stock Units0-26.96K (-100.00%)
Restricted Stock Units101.41K+74.39K (275.38%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-01-01 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Talasaz AmirAli CIK: 0001753159 Role: Director, Officer (Co-Chief Executive Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-01-01 | Code: J (Other acquisition/disposition) Shares: -13,209 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] Reflects changes in form of ownership from direct to indirect due to transfer of shares to Talasaz and Eskandari 2017 Family Trust. [Transaction #2] Security: Common Stock Date: 2026-01-01 | Code: J (Other acquisition/disposition) Shares: +13,209 | Price: $0.00 Shares Owned After: 2,096,311 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F1] Reflects changes in form of ownership from direct to indirect due to transfer of shares to Talasaz and Eskandari 2017 Family Trust. [Transaction #3] Security: Common Stock Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: +38,283 | Price: $0.00 Shares Owned After: 2,134,594 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust [Transaction #4] Security: Common Stock Date: 2026-01-01 | Code: F (Payment of exercise/tax) Shares: -19,402 | Price: $102.14 Total Value: $1,981,720.28 Shares Owned After: 2,115,192 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F2] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. [Transaction #5] Security: Common Stock Date: 2026-03-13 | Code: M (Exercise of derivative) Shares: +26,961 | Price: $0.00 Shares Owned After: 2,142,153 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust [Transaction #6] Security: Common Stock Date: 2026-03-13 | Code: F (Payment of exercise/tax) Shares: -13,664 | Price: $85.49 Total Value: $1,168,135.36 Shares Owned After: 2,128,489 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F2] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-01-01 | Code: M (Exercise of derivative) Shares: -38,283 | Price: $0.00 Shares Owned After: 77,727 | Ownership: D (Direct) Footnotes: [F3] This represents a restricted stock unit award granted on March 12, 2025 that vested with respect to 33% of the shares on January 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. [F4] Not applicable for Restricted Stock Units. [Transaction #2] Security: Performance-Based Restricted Stock Units Date: 2026-03-13 | Code: M (Exercise of derivative) Shares: -26,961 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F4] Not applicable for Restricted Stock Units. [Transaction #3] Security: Restricted Stock Units Date: 2026-03-17 | Code: A (Grant or award) Shares: +11,268 | Price: $0.00 Shares Owned After: 11,268 | Ownership: D (Direct) Footnotes: [F5] This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. [F4] Not applicable for Restricted Stock Units. [Transaction #4] Security: Restricted Stock Units Date: 2026-03-17 | Code: A (Grant or award) Shares: +101,409 | Price: $0.00 Shares Owned After: 101,409 | Ownership: D (Direct) Footnotes: [F6] This represents a restricted stock unit award granted on March 17, 2026 that vests over a three-year period. 33% of the shares subject to such award vests on January 1, 2027 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. [F4] Not applicable for Restricted Stock Units. --- Footnotes (Complete Index) --- F1: Reflects changes in form of ownership from direct to indirect due to transfer of shares to Talasaz and Eskandari 2017 Family Trust. F2: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. F3: This represents a restricted stock unit award granted on March 12, 2025 that vested with respect to 33% of the shares on January 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F4: Not applicable for Restricted Stock Units. F5: This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. F6: This represents a restricted stock unit award granted on March 17, 2026 that vests over a three-year period. 33% of the shares subject to such award vests on January 1, 2027 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. --- Signature --- /s/ /s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz (2026-03-17)

keid analysis is for reference only and does not constitute investment advice.